​​​​​

  • Transplant successfully utilizes organs from hepatitis C-positive donors

    The development of direct-acting antiviral (DAA) therapy has made it possible to successfully transplant HCV-positive organs.

  • New TB pill improves hard-to-treat cases

    Decades of ineffective treatment has resulted in TB strains that have become drug resistant and aren’t killed by common medicines.

  • Expanding therapeutic options in NETs

    What combination of new agents can help alter neuroendocrine tumors (NETs).

Our people are at the forefront of healthcare

Why Baylor Scott & White Health

We’ve created a transformative model for the health care industry that eliminates waste, improves coordination of care and helps us better manage chronic disease.

Medical Education

Baylor Scott & White has both clinical and research campuses for the Texas A&M Health Science Center (HSC) College of Medicine. In addition, we are an accredited provider for the Accreditation Council for Continuing Medical Education (ACCME).

Our Departments

Our extensive network of 48 hospitals and more than 900 patient care sites – including specialized centers, institutes and regional clinics – offers your patients a full range of medical expertise.

Innovation with a commitment to every patient

Improvement in a patient post-stroke in inpatient rehabilitation

A standing frame protocol was implemented for a 58-year-old man admitted to inpatient rehabilitation.

Neuro-Oncology Symposium

The purpose of the conference is to increase awareness and improve care for brain cancer patients.

Multiple Sclerosis Study

The purpose of this trial is to study the effect Tecfidera has in extending the time to a first attack in radiologically isolated syndrome (RIS) (ARISE).